ArticleBMJ open2022

Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocol.

Hiroki Osumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.